During the past decade, Resolution Psychopharmacology Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Resolution Psychopharmacology Research Institute" are "Schizophrenia" (2 trials). Many other conditions were trialed in "Resolution Psychopharmacology Research Institute" in a lesser frequency.

Most popular intervention types in "Resolution Psychopharmacology Research Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BI 425809" (1 trials), "Iclepertin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Resolution Psychopharmacology Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Resolution Psychopharmacology Research Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Resolution Psychopharmacology Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Resolution Psychopharmacology Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".